Market open
DaVita/$DVA
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About DaVita
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
Ticker
$DVA
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
76,000
ISIN
US23918K1088
Website
DaVita Metrics
BasicAdvanced
$11B
14.24
$10.11
1.14
-
Price and volume
Market cap
$11B
Beta
1.14
52-week high
$179.60
52-week low
$131.44
Average daily volume
883K
Financial strength
Current ratio
1.251
Quick ratio
1.125
Long term debt to equity
706.109
Total debt to equity
742.203
Interest coverage (TTM)
3.65%
Management effectiveness
Return on assets (TTM)
7.04%
Return on equity (TTM)
54.79%
Valuation
Price to earnings (TTM)
14.239
Price to revenue (TTM)
0.92
Price to book
-41.66
Price to tangible book (TTM)
-1.41
Price to free cash flow (TTM)
6.784
Growth
Revenue change (TTM)
5.11%
Earnings per share change (TTM)
14.90%
3-year revenue growth (CAGR)
3.74%
3-year earnings per share growth (CAGR)
6.11%
What the Analysts think about DaVita
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for DaVita stock.
DaVita Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
DaVita Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
DaVita News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for DaVita stock?
DaVita (DVA) has a market cap of $11B as of May 14, 2025.
What is the P/E ratio for DaVita stock?
The price to earnings (P/E) ratio for DaVita (DVA) stock is 14.24 as of May 14, 2025.
Does DaVita stock pay dividends?
No, DaVita (DVA) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next DaVita dividend payment date?
DaVita (DVA) stock does not pay dividends to its shareholders.
What is the beta indicator for DaVita?
DaVita (DVA) has a beta rating of 1.14. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.